PubMed Health⌕ Search

Biomedical subjects

A S Gidari

Publications and source records attributed to A S Gidari.

At least 19 recordsLinked to original sources

Effect of aminoglutethimide on murine fetal hepatic erythroid colony formation.

Pretreatment of pregnant mice with aminoglutethimide phosphate, an inhibitor of glucocorticoid synthesis, increases the content of fetal liver erythroid colony-forming cells (CFU-E), as assessed by the formation of erythroid colonies in vitro by fetal liver cells in plasma clots containing exogenous erythropoietin. In addition, the inability of aminoglutethimide to influence erythroid colony formation in vitro suggests that endogenous glucocorticoids exert a suppressive effect on the number of functional CFU-E in the fetal liver.

Aminoglutethimide↗

Effect of streptozotocin on the glutathione S-transferases of mouse liver cytosol.

Streptozotocin (STZ) increased the activity of mouse hepatic glutathione (GSH) S-transferases assayed with 1-chloro-2,4-dinitrobenzene. Nicotinamide administered prior to STZ prevented the hyperglycemia indicative of STZ-induced diabetes, but had no effect on the increase in GSH S-transferase activity caused by the drug. Another diabetogenic agent, alloxan, did not alter GSH S-transferase activity. Thus, streptozotocin may be increasing GSH S-transferase activity directly, and not as a result of the diabetic state the drug induces. Two transferases were characterized from mouse liver cytosol. One was a homodimer with a subunit molecular weight of about 28,000 and a pI of about 8.2. The other was also a homodimer with a subunit molecular weight of about 27,500 and a pI of about 9.2. The pI 8.2 GSH S-transferase was induced by STZ, while the pI 9.2 transferase was decreased by the drug. At least one other transferase appeared to be induced by STZ. Two other nitroso compounds, chlorozotocin and diethylnitrosamine, also increased GSH S-transferase activity, suggesting that this effect may be nitroso related.

Animals↗

Effect of dexamethasone on fetal liver erythroid colony-forming cells in vivo.

Pretreatment of pregnant mice (CD-1) with intravenous dexamethasone phosphate (10(-3)-10(-7) g/mouse), a synthetic glucocorticoid, reduced the number of erythroid colonies that formed when 15-day-old fetal liver erythroid progenitor cells (3 X 10(4] were cultured for two days in plasma clots containing exogenous erythropoietin (Epo) (25 mU). The proliferative rate of fetal liver erythroid colony-forming cells (CFU-E), obtained from pregnant mice treated 24 h earlier with dexamethasone phosphate (1 mg/mouse), was reduced from 76% (control) to 46% as measured by a decrease in the percentage of fetal liver CFU-E lost following a 20-min exposure to high-specific-activity tritiated thymidine (50 microCi, 50-77 Ci/mmol). In addition, pretreatment of pregnant mice with lower doses of dexamethasone phosphate (10(-5)-10(-7) g/mouse) resulted in a higher percentage of fetal liver CFU-E lost following exposure to high-specific-activity tritiated thymidine (64% and 67%, respectively). Concomitantly, the inhibitory effect of dexamethasone on erythroid colony formation by these fetal liver cells in response to exogenous Epo is reduced. These results appear to indicate that the dexamethasone-mediated reduction in erythroid colony formation is inversely related to the fraction of fetal liver CFU-E lost after exposure to high-specific-activity tritiated thymidine. Furthermore, this observation suggests that glucocorticoids inhibit erythroid colony formation by decreasing the proliferative rate of the fetal liver CFU-E.

Animals↗

Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow.

Dexamethasone, a prototypic synthetic glucocorticoid, was added to cultures of human fetal liver and adult marrow cells to assess its effects on erythroid colony and burst formation. Dexamethasone decreased the number of fetal liver erythroid colonies and bursts formed in the presence of erythropoietin, and also decreased the number of cells per colony. The amount and type of haemoglobin produced per cell were unaffected by adding dexamethasone to the cultures. Dexamethasone inhibited the incorporation of 3H-thymidine into DNA in fetal liver cells stimulated with erythropoietin, supporting the hypothesis that dexamethasone inhibits the proliferation but not the differentiation of fetal liver CFU-E and BFU-E. In contrast, addition of dexamethasone to adult bone marrow cultures had a variable effect on erythroid colony and burst formation.

Adult↗

Inhibition of steroid-mediated induction of delta-aminolevulinic acid synthase by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A).

The inhibition of the steroid-mediated induction of delta-aminolevulinate synthase, the rate-limiting enzyme in hepatic porphyrin-heme biosynthesis, by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A) as studied in cultured chick embryo liver cells. The formation of porphyrins in response to cyproterone, a synthetic steroid, was inhibited in a time-dependent manner by SKF 525-A, an inhibitor of several drug metabolizing enzyme systems. This action is a result of an inhibitory effect of SKF 525-A on the cyproterone-mediated induction of delta-aminolevulinate synthase; SKF 525-A also inhibited the induction of the enzyme by the naturally occurring 5 beta-H steroids, etiocholanolone and pregnanolone. Employing [3H]etiocholanolone, we provide evidence that this inhibition is not associated with either decreased uptake or an altered metabolism of the steroid. Moreover, approx 4-6-fold more radioactivity was associated with [3H]etiocholanolone-treated cells cultured in the presence of SKF 525-A. Alternative mechanisms for the induction of delta-aminolevulinate synthase by steroids are proposed which do not require the interaction of steroid-receptor complex with the genome.

5-Aminolevulinate Synthetase↗

Glucocorticoids inhibit the growth of murine fetal liver erythroid burst-forming cells.

The effects of glucocorticoids on the formation of large colonies of erythroid cells, termed "bursts," by erythroid burst-forming units (BFU-E) obtained from murine fetal liver were studied in plasma clot cultures. Fetal liver erythroid progenitor cells formed a reduced number of erythroid bursts when cultured for 9 days in the presence of dexamethasone. Similar results were obtained with other glucocorticoids, including corticosterone, cortisol, prednisone, prednisolone, and 9 alpha-fluorocortisol; in contrast, neither 11 alpha-cortisol, tetrahydrocortisol, nor progesterone influenced erythroid burst formation. Erythroid burst formation was also decreased by the addition of dexamethasone on days 5, 7, and 9 to developing erythroid bursts, indicating that the growth of BFU-E-derived erythroid precursor cells was also reduced by the glucocorticoid. The formation of erythroid bursts by murine fetal liver cells was also reduced when the cells were incubated with dexamethasone (10(-7) and 10(-8) M) for 1 h, washed, and cultured in plasma clots; the concentration of dexamethasone was reduced by the washes to levels which do not inhibit the growth of BFU-E derived erythroid progenitor cells. Similar results were obtained with various other glucocorticoids (10(-7) M). These studies demonstrate that glucocorticoids exert a suppressive effect on the formation of erythroid bursts by murine fetal liver erythroid progenitor cells, and that this effect is the net result of inhibitory effects on the BFU-E and its progeny.

Animals↗

Identification of a glucocorticoid receptor in the human leukemia cell line K562.

The binding of [3H]dexamethasone to the cytosol fraction prepared from the human leukemia cell line K562 was studied with a competitive binding assay. Specific, saturable binding was identified by incubating cytosol with increasing concentrations of [3H]dexamethasone in the presence and absence of nonlabeled dexamethasone. A Scatchard plot of the data was linear, suggesting the presence of a single class of binding sites with KD = 2.49 +/- 0.23 x 10(-8)M. The binding sites appear to be protein in nature, since specific binding was reduced by treatment of the cytosol with trypsin, pronase, and heat; neither DNase nor RNase affected the binding. Binding was also reduced in the absence of alpha-thioglycerol and in the presence of p-chloromercuribenzoate and N-ethylamaleimide, suggesting that optimal binding activity requires reduced sulfhydryl groups. The binding site appears to be specific for glucocorticoids as evaluated in competition studies. Finally, glucocorticoids were found to inhibit the clonal growth of K562 cells in vitro, suggesting a potential role for glucocorticoid binding sites in the modulation of K562 cell proliferation.

Animals↗

Glucocorticoid-mediated inhibition of erythroid colony formation by mouse bone marrow cells.

The ability of bone marrow cells, obtained from mice pretreated with the synthetic glucocorticoid dexamethasone, to form erythroid colonies in vitro was studied. The results show that these bone marrow cells form a reduced number of erythroid colonies in vitro in response to Epo. This effect is evident after single injection (1 mg, intraperitoneally) of dexamethasone (46% of control values) and is at a maximum after two to four consecutive treatments (12% to 17% of control values). In order to eliminate the influence of either influx or efflux of cells to or from the bone marrow, the effect of dexamethasone on erythroid colony formation in vitro was examined. In these experiments, bone marrow cells cultured in the presence of Epo (25 microU) and dexamethasone (2 X 10(-6)M to 2 X 10(-8)M) formed fewer erythroid colonies than cells cultured in the presence of Epo alone. The ability of the antiglucocorticoid, 17 alpha-methyltestosterone (2 X 10(-7)M) to reverse this dexamethasone-mediated inhibition of erythroid colony formation suggests that this phenomenon is mediated through a glucocorticoid receptor. These studies show therefore that dexamethasone, either in vivo or in vitro, decreases the number and/or functional capacity of adult murine bone marrow cells capable of forming erythroid colonies in vitro in response to Epo, although the precise mechanism of this inhibition remains to be established.

Animals↗

Refractory anemia with hyperplastic bone marrow: subclassification based on responsiveness to erythropoietin in vitro.

The responsivenes to erythropoietin of cultured bone marrow cells, obtained from 7 patients with refractory anemia with hyperplastic marrow, was studied. 5 of these patients' marrows also exhibited sideroblasti changes. Heme synthesis in cultured bone marow cells was either responsive to stimulation by erythropoietin, or completely refractory. The sensitivity of the bone marrow cells to the hormone was not related to either the clinical or laboratory findings.

Aged↗

Cyproterone-mediated stimulation of delta-aminolevulinic acid synthetase in chick embryo liver cells.

In cultured chick embryo liver cells, cyproterone and cyproterone acetate, synthetic anti-androgenic steroids, were found to be potent inducers of mitochondrial delta-aminolevulinic acid (ALA) synthetase, the rate-limiting enzyme in the heme biosynthetic pathway. Both steroids produced a detectable increase in enzyme activity at 5 muM and a maximal stimulation, 36-fold for cyproterone and 29-fold for cyproterone acetate, at 55 muM. The dose-response curves of the steroids differed, however, in that cyproterone acetate produced a greater mean stimulation of the enzyme at concentrations less than approximately 25 muM, whereas, at higher concentrations, cyproterone was the more effective inducer. Increased activity of ALA synthetase was not apparent until about 12 hours after the addition of cyproterone, and maximal activity was not achieved until 20-24 hours. The induction of ALA synthetase by these anti-androgens was prevented by actinomycin D, cordycepin, anisomycin, cycloheximide, and puromycin. These results suggest that new RNA and protein synthesis are necessary for enzyme induction. The cyproterone-mediated induction of the enzyme was inhibited 50% by 2 muM heme, the putative physiological inhibitor of ALA synthetase. These antiandrogens, unlike other potent steroid inducers of this enzyme in chick embryo liver, do not possess either a 5beta-pregnane or 5beta-androstane nucleus. The stimulation of hepatic ALA synthetase represents the first example of a direct effect of these steroids on enzyme induction.

5-Aminolevulinate Synthetase↗

Cytoplasmic receptor protein for etiochalanolone in chick embryo liver.

Acute intermittent porphyria is a gentic disease associated with changes in the activity of some of the hepatic enzymes in the heme biosynthetic pathway and in the activity of delta4-5alpha-steroid reductase, an enzyme involved in steroid metabolism. Embryonic chick liver has been used as a model system to study the effects of several naturally occurring 5beta steroid metabolites on delta-aminolevulinic acid synthetase, the rate-limiting enzyme in the heme pathway (Granick, S., and Kappas, A. (1967) J. Biol. Chem. 242, 4587-4593). In this study we have identified in vitro a hepatic cytoplasmic receptor which binds [3H]-etiocholanolone (a 5beta-H androgen metabolite). The steroid-receptor complex has an apparent Kd value of 3.5 times 10(-6) M at 0-4degrees; the number of binding sites per cell is 23,000. The macromolecular complex sediments at approximately 4 S in a 5 to 20% sucrose gradient and is unaffected by KCl concentrations up to 0.4 M. The steroid-receptor complex can be destroyed by heat (60degrees) or proteolytic digestion and is inhibited by sulfhydryl-blocking agents. Competition studies revealed that among the nonradioactive steroids tested, all of the primary androgens and the progestins as well as their 5alpha and 5beta metabolites block the binding of [3H]etiochalanolone. Only the glucuronide derivative of etiocholanolone, glucocorticoids and their metabolites, 17beta-estradiol, and cyproterone compete poorly for the receptor. The steroid receptor described here appears to be different from the androgen receptor isolated from rat liver and prostate.

Animals↗